These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3134596)

  • 61. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
    Hsu MF; Chang LC; Chen SC; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2008 Nov; 598(1-3):123-31. PubMed ID: 18834875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phospholipase A2 modulation by calmodulin, prostaglandins and cyclic nucleotides.
    Moskowitz N; Shapiro L; Schook W; Puszkin S
    Biochem Biophys Res Commun; 1983 Aug; 115(1):94-9. PubMed ID: 6311214
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adenosine promotes neutrophil chemotaxis.
    Rose FR; Hirschhorn R; Weissmann G; Cronstein BN
    J Exp Med; 1988 Mar; 167(3):1186-94. PubMed ID: 2832507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Suppression of polymorphonuclear leucocyte chemotaxis by Pseudomonas aeruginosa elastase in vitro: a study of the mechanisms and the correlation with ring abscess in pseudomonal keratitis.
    Ijiri Y; Matsumoto K; Kamata R; Nishino N; Okamura R; Kambara T; Yamamoto T
    Int J Exp Pathol; 1994 Dec; 75(6):441-51. PubMed ID: 7734333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of N-acetylchito-oligosaccharides on activation of phagocytes.
    Suzuki K; Tokoro A; Okawa Y; Suzuki S; Suzuki M
    Microbiol Immunol; 1986; 30(8):777-87. PubMed ID: 3784930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
    Quitt M; Torres M; McGuire W; Beyer L; Coates TD
    J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.
    Clancy RM; Dahinden CA; Hugli TE
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7200-4. PubMed ID: 6417666
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
    Bauldry SA; McCall CE; Cousart SL; Bass DA
    J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
    Gonder JC; Thomas JM; Payne ES
    Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
    Partsch G; Schwarzer C
    J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phospholipase A2 activation in chemotactic peptide-stimulated HL60 granulocytes: synergism between diacylglycerol and Ca2+ in a protein kinase C-independent mechanism.
    Billah MM; Siegel MI
    Biochem Biophys Res Commun; 1987 Apr; 144(2):683-91. PubMed ID: 3107559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C; Fehr J
    J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils.
    Chen LW; Lin MW; Hsu CM
    J Biomed Sci; 2005; 12(2):311-9. PubMed ID: 15917990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stimulation and inhibition of neutrophil chemotaxis by endothelin-3.
    Elferink JG; de Koster BM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S142-4. PubMed ID: 8587345
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
    Angle MJ; McManus LM; Pinckard RN
    Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Priming of human polymorphonuclear leukocytes with granulocyte-macrophage colony-stimulating factor involves protein kinase C rather than enhanced calcium mobilisation.
    Schatz-Munding M; Ullrich V
    Eur J Biochem; 1992 Mar; 204(2):705-12. PubMed ID: 1541284
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils.
    Howard TH; Oresajo CO
    J Cell Biol; 1985 Sep; 101(3):1078-85. PubMed ID: 4040915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of various drugs on superoxide generation, arachidonic acid release and phospholipase A2 in polymorphonuclear leukocytes.
    Taniguchi K; Urakami M; Takanaka K
    Jpn J Pharmacol; 1988 Mar; 46(3):275-84. PubMed ID: 2898031
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.
    Mrowietz U; Schröder JM; Christophers E
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1223-8. PubMed ID: 3390181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.